Scarica l'app Stockscreener
4.29
8.72%
-0.41
Co Diagnostics Inc Borsa (CODX) Ultime notizie
Co-Diagnostics Signs Exclusive Distribution Deal With Mexican Partner; Shares Rise Pre-Bell - Moomoo
Co-Diagnostics develops Ebola assay strategy following WHO emergency alert (CODX) - MSN
Co-Diagnostics (CODX) Expands Distribution Agreement in Mexico - GuruFocus
Co-Diagnostics signs exclusive Mexico distribution deal - Investing.com
Co-Diagnostics signs exclusive Mexico distribution deal By Investing.com - Investing.com Canada
Co-Diagnostics Expands Commercialization Network In Latin America With Exclusive Mexico Distribution Agreement - marketscreener.com
Co-diagnostics Company Profile & Introduction - Moomoo
CODX Q1 2026 Earnings: EPS Falls Short of Estimates as Company Continues Strategic PivotDividend Increase Stocks - newsline.com
Co-diagnostics(CODX) Stock Options Chain | Quotes & News - Moomoo
CODX Q1 2026 Earnings: Wider-than-Expected Loss as Revenue Remains NilQuarterly Earnings - newsline.com
CODX Stock Price, Quote & Chart - ChartMill
OpenAI's Major Overhaul: Aiming for Growth Before IPO - GuruFocus
Co-Diagnostics Invited to Present at Stop TB Partnership Summit in Washington, D.C. - Eastern Progress
symbol__ Stock Quote Price and Forecast - CNN
Jane Street Group, LLC's Strategic Acquisition of Co-Diagnostics Inc Shares - GuruFocus
Jane Street entities report 6.4% stake in Co-Diagnostics (CODX) - Stock Titan
Co-Diagnostics (CODX) FDA Approvals, PDUFA Dates & Drug Alerts 2026 - MarketBeat
Co-Diagnostics advances Ebola PCR test development program - Investing.com UK
Co-Diagnostics (CODX) Advances Ebola PCR Development Program - GuruFocus
Co-Diagnostics advances Ebola PCR test development program By Investing.com - Investing.com South Africa
Co-Diagnostics and CoSara Advance Ebola PCR Test Development and Co-Dx™ PCR Point-of-Care Platform Capabilities - StreetInsider
Co-Diagnostics and CoSara Advance Ebola PCR Test Development and Co-Dx™ PCR Point-of-Care Platform Capabilities – Company AnnouncementFT.com - Financial Times
Q4 2025 Co-Diagnostics Inc Earnings Call Transcript - GuruFocus
Q1 2026 Co-Diagnostics Inc Earnings Call Transcript - GuruFocus
[EFFECT] Co-Diagnostics, Inc. SEC Filing - Stock Titan
Is Co-Diagnostics National Security's next diagnostic pick? - MSN
CODX - Finviz
$Co-diagnostics (CODX.US)$ Fuhh... - Moomoo
Co-Diagnostics: Offering Expected to Close on or About May 21 >CODX - Moomoo
Co-Diagnostics (CODX) registers 4.94M shares for resale; up to $5.18M possible - Stock Titan
Is Co-Diagnostics National Security’s Next Diagnostic Pick? - Investing.com
Is Co-Diagnostics National Security’s Next Diagnostic Pick? - MarketBeat
$Co-diagnostics (CODX.US)$ more the boyzzz want - Moomoo
Co-Diagnostics (CODX) Q4 2025 Earnings Transcript - AOL.com
Co-Diagnostics (NASDAQ: CODX) CEO nets RSU shares after tax sale - Stock Titan
Co-Diagnostics (NASDAQ: CODX) CFO reports RSU vesting and tax-related share sale - Stock Titan
Co-Diagnostics (NASDAQ: CODX) president nets RSU shares after tax sale - Stock Titan
Co-Diagnostics (CODX) director receives 1,695-share equity grant - Stock Titan
Director at Co-Diagnostics (NASDAQ: CODX) receives 1,695-share equity grant - Stock Titan
[Form 4] Co-Diagnostics, Inc. Insider Trading Activity - Stock Titan
Co-Diagnostics (NASDAQ: CODX) director awarded 1,695 shares and exercises RSUs - Stock Titan
$Co-diagnostics (CODX.US)$ - Moomoo
Co-Diagnostics (CODX) Enhances PCR Assay Development for Ebola O - GuruFocus
Co-Diagnostics Shares Surge as Investors React to Ebola-test Development Update and Outbreak Headlines - Moomoo
Co-Diagnostics shares surge as investors react to Ebola-test development update and outbreak headlines - Quiver Quantitative
CODX Stock Explodes Over 630% In Six Sessions – Retail Traders Bet The Rally Isn’t Over Yet - Yahoo Finance
Co-Diagnostics Advances Ebola Pcr Assay Development Strategy with Joint Venture Cosara - marketscreener.com
21.00 🙏 - Moomoo
CODX Stock Rockets As Saudi Facility And Ebola Assay Shift Outlook - StocksToTrade
1.64%
0.76%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):